Estrogen markedly increases LDL-receptor activity in hypercholesterolemic patients

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Molecular Biology

Background:

• Hypercholesterolemia (HC) is characterized by elevated cholesterol levels, increasing cardiovascular risk.
• Low-density lipoprotein receptor (LDL-R) dysfunction is a key factor in HC pathogenesis.
• Estrogen's role in modulating lipid metabolism and LDL-R activity warrants further investigation.

Purpose of the Study:

• To investigate the effect of estrogen administration on LDL-R activity in patients with hypercholesterolemia.
• To determine the correlation between LDL-R activity and serum lipid levels (TC and LDL-C).
• To assess the therapeutic potential of estrogen in managing HC by improving LDL-R function.

Main Methods:

• Fluorocytometry was used to measure LDL-R activity in 16 HC patients and 133 healthy controls.
• Serum total cholesterol (TC) and LDL cholesterol (LDL-C) levels were quantified.
• Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE) was employed to screen for common LDL-R gene mutations.

Main Results:

• Three HC patients exhibited low LDL-R activity (<80%) with very high TC and LDL-C levels.
• A significant inverse correlation was observed between LDL-R activity and serum TC/LDL-C levels (p<0.05).
• Estriol administration normalized LDL-R activity and reduced TC/LDL-C in two women with initially low activity.
• One male patient with extremely low LDL-R activity showed no common LDL-R gene mutations.

Conclusions:

• Estrogen administration can increase LDL-R activity in hypercholesterolemia patients.
• This increase in LDL-R activity contributes to the reduction of serum TC and LDL-C levels.
• Estrogen may serve as a therapeutic agent for HC, especially in patients with impaired LDL-R function.